Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure

Table 1

Serum biochemistry, prior to binder treatment.

CRF group/binder type		Weight; g	Creatinine; µmol/L	Ca; mmol/L	P; mmol/L
CRF control	18	216 ± 4	251 ± 17.7	2.27 ± 0.40	4.83 ± 0.28
CRF PA21	19	217 ± 4	239 ± 19.0	2.44 ± 0.04	4.75 ± 0.32
CRF Se	20	211 ± 3	229 ± 16.2	2.42 ± 0.06	4.44 ± 0.23
CRF La	18	216 ± 4	233 ± 10.6	2.41 ± 0.03	4.62 ± 0.21

Ca, calcium; La, lanthanum carbonate; P, phosphorus; Se, sevelamer carbonate; PA21, sucroferric oxyhydroxide. Values shown are mean ± SE.